Related Experiment Video
Updated: Jun 16, 2026

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia
Published on: September 5, 2019
Peroxisomal Lipid Metabolism as a Therapeutic Target in Leukemia
Ekaterina N Parfenova1, Paul A Spagnuolo1
1Department of Food Science, University of Guelph, Guelph, Ontario, Canada.
None:
Lipid delivery and metabolism profoundly shape cancer cell fate, energy balance, redox control, and therapy resistance. Peroxisomes regulate fatty acid oxidation (FAO) and oxidative homeostasis with growing relevance in hematologic malignancies. Recent studies show peroxisomal FAO (pFAO) is selectively elevated in acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL), sustaining cancer cell survival under metabolic and therapeutic stress. Elevated ACOX1, ABCD1/2, CROT, and PEX5 expression underscores leukemia-specific peroxisomal vulnerability; their pharmacologic or genetic inhibition disrupts lipid homeostasis, induces very-long-chain fatty acid accumulation, and drives oxidative stress and lipotoxicity. This selectively kills leukemia cells while sparing normal progenitors. pFAO blockade synergizes with chemotherapy drugs such as venetoclax and cytarabine, enabling exploitation of metabolic vulnerabilities to improve therapeutic outcomes. Upstream, PPAR isoforms transcriptionally link lipid ligand sensing to peroxisomal gene expression, though their precise role in governing pFAO in leukemia remains undefined. Integrating solid tumor and leukemia insights, peroxisomes emerge as dynamic lipid-processing organelles coupling FAO, redox buffering, and inter-organelle exchange to cancer persistence. Targeting peroxisome-mediated lipid delivery offers a frontier for overcoming metabolic resilience and therapeutic resistance in leukemia.
Related Concept Videos
Peroxisomes
Peroxisomes
Peroxisomes
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
